store at low temperature
store at -80°C
Clivatuzumab is a humanized anti-myxinomab, which can target the MUC1 epitope highly expressed on the surface of most pancreatic cancer cells, and has a good therapeutic effect on a variety of tumor cells.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 328.00 | |
5 mg | In stock | $ 863.00 | |
10 mg | In stock | $ 1,380.00 |
Description | Clivatuzumab is a humanized anti-myxinomab, which can target the MUC1 epitope highly expressed on the surface of most pancreatic cancer cells, and has a good therapeutic effect on a variety of tumor cells. |
In vitro | Clivatuzumab exhibits high specificity for pancreatic ductal adenocarcinoma (PDAC), showing minimal reactivity towards normal and benign non-tumorous pancreatic tissues. Although it demonstrates limited reactivity (approximately 10% of all samples) towards adenocarcinomas in certain other organs such as the stomach, colon, and lungs [1]. |
Molecular Weight | N/A |
CAS No. | 1622075-09-5 |
store at low temperature
store at -80°C
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Clivatuzumab 1622075-09-5 Others inhibitor inhibit